Risk reduction of ASCVD attributed to lowering of remnant cholesterol from statins, fibrates, APOC3 inhibitors, and ANGPTL3 inhibitors: a cohort study
用户wxb8loTerxGI
17天前
30
10
已完结
1. 系统已在2025-09-24 11:27:58对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1016/j.atherosclerosis.2025.120471
文献链接: https://linkinghub.elsevier.com/retrieve/pii/S0021915025013693
其他信息:
出版社: Elsevier BV
作者: Mie Balling; Otto Grøn Roepstorff; Thomas Alexander Gerds; Anette Varbo; Martin Bødtker Mortensen; Anne Langsted; Børge Grønne Nordestgaard; Shoaib Afzal
